AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10733159 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 8934602 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equations for ordinal data
Number of subjects: 0
Study 8934602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative odds ratio
Number of subjects: 0
Study 8934602 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equation methodology
Number of subjects: 0
Study 1680573 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 20, 30, or 40 micrograms.kg‐1
Number of subjects: 37
Study 6185289 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripotassium-dicitratobismuthate
Number of subjects: 100
Study 6185289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29098393 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX (1 μg/kg loading dose over 10 min, followed by 0.3-0.5 μg/kg/h continuous infusion)
Number of subjects: 70
Study 29098393 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX
Number of subjects: 70
Study 29098393 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 70
Study 28132000 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT (Stressbusters)
Number of subjects: 91
Study 28132000 — intervention group
Group type: COMPARATOR
Intervention: Attention control (self-help websites)
Number of subjects: 91
Study 25388882 — intervention group
Group type: EXPERIMENTAL
Intervention: HydraCoach(®) water bottle
Number of subjects: 32
Study 25388882 — intervention group
Group type: COMPARATOR
Intervention: Standard education control group
Number of subjects: 32
Study 23946732 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal meperidine
Number of subjects: 30
Study 23946732 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral meperidine
Number of subjects: 30
Study 23946732 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 30
Study 21248232 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodule growth assessment by 9 radiologists
Number of subjects: 100
Study 21248232 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodule presence assessment by 9 radiologists
Number of subjects: 100
Study 21248232 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive screening result assessment by 9 radiologists
Number of subjects: 100
Study 21248232 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in margins and attenuation assessment by 9 radiologists
Number of subjects: 100
Study 21248232 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up recommendations assessment by 9 radiologists
Number of subjects: 100
Study 17433840 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on therapy with irbesartan (300 mg/day)
Number of subjects: 50
Study 17433840 — intervention group
Group type: COMPARATOR
Intervention: Control group (continuation of conventional therapy)
Number of subjects: 50
Study 17038903 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic techniques
Number of subjects: 1450
Study 17038903 — intervention group
Group type: EXPERIMENTAL
Intervention: Open donor nephrectomy
Number of subjects: 1450
Study 17038903 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic donor nephrectomy
Number of subjects: 1450
Study 17038903 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic flank incision
Number of subjects: 1450
Study 17038903 — intervention group
Group type: COMPARATOR
Intervention: Open techniques
Number of subjects: 1450
Study 14870620 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole against hookworm and praziquantel against schistosomiasis
Number of subjects: 1115
Study 14870620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1115
Study 14870620 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 1115
Study 11572739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 837
Study 11572739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 837
Study 9420364 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing (EMDR)
Number of subjects: 43
Study 9420364 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list procedure
Number of subjects: 43
Study 9420364 — intervention group
Group type: COMPARATOR
Intervention: Same treatment without the eye movement
Number of subjects: 43
Study 8499201 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 0
Study 8499201 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0
Study 3087076 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (3 X 300 mg per day for 9 days as continuous intravenous infusion)
Number of subjects: 50
Study 3087076 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate mesilate
Number of subjects: 50
Study 3087076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31157716 — intervention group
Group type: EXPERIMENTAL
Intervention: PVR VT
Number of subjects: 150
Study 31157716 — intervention group
Group type: COMPARATOR
Intervention: PVR-free VT
Number of subjects: 150
Study 29326153 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloons (DCB)
Number of subjects: 331
Study 29326153 — intervention group
Group type: COMPARATOR
Intervention: Standard Percutaneous Transluminal Angioplasty (PTA)
Number of subjects: 331
Study 26212693 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium alginate packing
Number of subjects: 27
Study 26212693 — intervention group
Group type: COMPARATOR
Intervention: Carboxymethyl cellulose packing
Number of subjects: 27
Study 24635772 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% albumin and crystalloid solution
Number of subjects: 1818
Study 24635772 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid solution alone
Number of subjects: 1818
Study 23200687 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners
Number of subjects: 1620
Study 23200687 — intervention group
Group type: COMPARATOR
Intervention: Women
Number of subjects: 1620
Study 21518135 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of metformin
Number of subjects: 60
Study 21518135 — intervention group
Group type: EXPERIMENTAL
Intervention: 1700 mg of metformin
Number of subjects: 60
Study 19062610 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study 19062610 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs)
Number of subjects: 0
Study 19062610 — intervention group
Group type: COMPARATOR
Intervention: Preventive or alleviating interventions
Number of subjects: 0
Study 17003660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 73
Study 17003660 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication (sertraline)
Number of subjects: 73
Study 17003660 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cognitive-behavioral therapy and antidepressant medication
Number of subjects: 73
Study 14604304 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 8
Study 14604304 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 8
Study 14604304 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 8
Study 14604304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10952585 — intervention group
Group type: COMPARATOR
Intervention: Quinine (Q(7)) alone
Number of subjects: 204
Study 10952585 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine (Q(7)) in combination with clindamycin (Q(7)C(7))
Number of subjects: 204
Study 10952585 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine (Q(7)) in combination with tetracycline (Q(7)T(7))
Number of subjects: 204
Study 8831988 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CY) (4 g/m2) alone (group I)
Number of subjects: 15
Study 8831988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CY) (4 g/m2) with recombinant human granulocyte‐macrophage colony stimulating factor (rhGM‐CSF) (5 micrograms/kg/day) (group II)
Number of subjects: 15
Study 8831988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CY) (4 g/m2) with rhGM‐CSF (group II)
Number of subjects: 15
Study 1293274 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibro-acoustic stimulation (VAS) for 5 sec at the beginning of one of the two 60 min FHR recordings
Number of subjects: 17
Study 1293274 — intervention group
Group type: COMPARATOR
Intervention: Control period (no VAS)
Number of subjects: 17
Study 3515865 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide (5 mg)
Number of subjects: 9
Study 3515865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30293014 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate psychomotor agitation
Number of subjects: 630
Study 30293014 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe psychomotor agitation
Number of subjects: 630
Study 30293014 — intervention group
Group type: COMPARATOR
Intervention: Non-agitated patients
Number of subjects: 630
Study 30293014 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately agitated patients
Number of subjects: 630
Study 30293014 — intervention group
Group type: COMPARATOR
Intervention: Severely agitated patients
Number of subjects: 630
Study 27592734 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular procedures
Number of subjects: 549
Study 27592734 — intervention group
Group type: COMPARATOR
Intervention: Open procedures
Number of subjects: 549
Study 24291168 — intervention group
Group type: EXPERIMENTAL
Intervention: LT patch (37.5 μg of ETEC LT)
Number of subjects: 2036
Study 24291168 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 2036
Study 24291168 — intervention group
Group type: EXPERIMENTAL
Intervention: LT patch
Number of subjects: 2036
Study 22588842 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (AF patients with pacemaker implantation)
Number of subjects: 66
Study 22588842 — intervention group
Group type: COMPARATOR
Intervention: Group B (patients with dual-chamber pacing)
Number of subjects: 66
Study 22588842 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Group A and Group B at follow-up
Number of subjects: 66
Study 20865842 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75% imiquimod cream
Number of subjects: 247
Study 20865842 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 247
Study 18562771 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein, low-calorie diet with 3-g/day fish-oil supplementation
Number of subjects: 11
Study 18562771 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 11
Study 16311278 — intervention group
Group type: EXPERIMENTAL
Intervention: Bougie-guided technique
Number of subjects: 120
Study 16311278 — intervention group
Group type: COMPARATOR
Intervention: Digital technique
Number of subjects: 120
Study 16311278 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 120
Study 12732415 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 40
Study 12732415 — intervention group
Group type: EXPERIMENTAL
Intervention: non‐tobacco mint snuff
Number of subjects: 40
Study 12732415 — intervention group
Group type: EXPERIMENTAL
Intervention: brand switching
Number of subjects: 40
Study 12732415 — intervention group
Group type: EXPERIMENTAL
Intervention: elimination of ST use in specific situations
Number of subjects: 40
Study 11126693 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel anticancer agents targeting signal transduction and antiangiogenesis
Number of subjects: 0
Study 11126693 — intervention group
Group type: COMPARATOR
Intervention: Classical cytotoxic agents
Number of subjects: 0
Study 8834412 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 14
Study 1483669 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% ethanolamine oleate (EO)
Number of subjects: 66
Study 1483669 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% ethanolamine oleate plus 1% polidocanol (EOP)
Number of subjects: 66
Study 6437295 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled metaproterenol 10 minutes prior to exercise, in addition to theophylline (serum level 10-20 micrograms/ml)
Number of subjects: 53
Study 6437295 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metaproterenol and cromolyn with theophylline
Number of subjects: 53
Study 31868201 — intervention group
Group type: EXPERIMENTAL
Intervention: mLP formula (1.7 g protein/100 kcal)
Number of subjects: 90
Study 31868201 — intervention group
Group type: COMPARATOR
Intervention: CTRL formula (2.1 g protein/100 kcal)
Number of subjects: 90
Study 31868201 — intervention group
Group type: EXPERIMENTAL
Intervention: mLP formula
Number of subjects: 90
Study 31868201 — intervention group
Group type: COMPARATOR
Intervention: CTRL formula
Number of subjects: 90
Study 31868201 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formula groups
Number of subjects: 90
Study 31870453 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene champions' role in improving hand hygiene compliance through peer coaching and education.
Number of subjects: 173
Study 31870453 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategies involving HH champions.
Number of subjects: 173
Study 31870453 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional application of the implementation strategy for HH champions.
Number of subjects: 173
Study 26884380 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care for conduct and substance use problems
Number of subjects: 205
Study 26884380 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline symptom severity
Number of subjects: 205
Study 26884380 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-occurring developmental psychopathology characteristics
Number of subjects: 205
Study 26884380 — intervention group
Group type: EXPERIMENTAL
Intervention: Change over time in developmental psychopathology characteristics (peer delinquency, depression)
Number of subjects: 205
Study 25198101 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded care coordinator (ECC) services including telephone calls at set intervals post-discharge (24 hours, 2, 4, 8, 12 weeks, 5, 7, 9 months)
Number of subjects: 81
Study 25198101 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient care
Number of subjects: 81
Study 23647176 — intervention group
Group type: EXPERIMENTAL
Intervention: Social mindfulness (operationalized in a social decision-making paradigm)
Number of subjects: 0
Study 23647176 — intervention group
Group type: EXPERIMENTAL
Intervention: Social mindfulness (socially mindful person)
Number of subjects: 0
Study 23647176 — intervention group
Group type: EXPERIMENTAL
Intervention: Social mindfulness (trustworthy faces)
Number of subjects: 0
Study 23647176 — intervention group
Group type: EXPERIMENTAL
Intervention: Social mindfulness (personality traits)
Number of subjects: 0
Study 21385806 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly administration of low dose, high frequency ultrasound therapy (0.5 W/cm², 1 MHz, pulsed pattern of 1:4) for up to 12 weeks plus standard care
Number of subjects: 337
Study 21385806 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 337
Study 21385806 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly administration of low dose, high frequency ultrasound therapy
Number of subjects: 337
Study 21385806 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 337
Study 21385806 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ulcer area
Number of subjects: 337
Study 21385806 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ulcer duration
Number of subjects: 337
Study 19092122 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux membranes
Number of subjects: 738
Study 19092122 — intervention group
Group type: COMPARATOR
Intervention: Low-flux membranes
Number of subjects: 738
Study 16418201 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation package
Number of subjects: 1334
Study 16418201 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme
Number of subjects: 1334
Study 16418201 — intervention group
Group type: COMPARATOR
Intervention: Usual general practice care
Number of subjects: 1334
Study 12915774 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Acetate
Number of subjects: 108
Study 12915774 — intervention group
Group type: COMPARATOR
Intervention: Sevelamer
Number of subjects: 108
Study 11206213 — intervention group
Group type: EXPERIMENTAL
Intervention: Tack box presented empty
Number of subjects: 3
Study 11206213 — intervention group
Group type: COMPARATOR
Intervention: Tack box presented full of tacks
Number of subjects: 3
Study 9366940 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltanolone (0.2 mg/kg in elderly, 0.3 mg/kg in young)
Number of subjects: 113
Study 9366940 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltanolone
Number of subjects: 113
Study 1394027 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 0
Study 1394027 — intervention group
Group type: COMPARATOR
Intervention: RIMA compounds (including moclobemide)
Number of subjects: 0
Study 4082604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport and Autogenic Training (AT)
Number of subjects: 19
Study 4082604 — intervention group
Group type: COMPARATOR
Intervention: Sport only
Number of subjects: 19
Study 31941353 — intervention group
Group type: COMPARATOR
Intervention: Upright posture
Number of subjects: 81
Study 30063150 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental caries
Number of subjects: 1204
Study 30063150 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental caries with TDI and malocclusion
Number of subjects: 1204
Study 30063150 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1204
Study 28348152 — intervention group
Group type: EXPERIMENTAL
Intervention: SAL200 (0.1, 0.3, 1, 3, and 10 mg/kg of body weight)
Number of subjects: 0
Study 26153174 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded mothers' voices played for the newborns before and after blood sampling procedure
Number of subjects: 30
Study 26153174 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 24223034 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin 0.2 mg nocte
Number of subjects: 55
Study 22032706 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 6080
Study 22032706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6080
Study 18714152 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine 1 g orally 3 times a day for 4 weeks
Number of subjects: 12
Study 18714152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17138063 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab induction therapy followed by FK506 monotherapy
Number of subjects: 0
Study 17138063 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunosuppression (FK506, mycophenolate mofetil and steroids) without any induction agent
Number of subjects: 0
Study 14633147 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) enoxaparin
Number of subjects: 25
Study 14633147 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 25
Study 10483579 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 Mio. interferon beta‐1b subcutaneously every second day for two to three years
Number of subjects: 718
Study 10483579 — intervention group
Group type: COMPARATOR
Intervention: Placebo subcutaneously every second day for two to three years
Number of subjects: 718
Study 8942591 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position during IT injection of dextrose-free bupivacaine 0.25% with fentanyl 0.005%
Number of subjects: 20
Study 8942591 — intervention group
Group type: COMPARATOR
Intervention: Lateral position during IT injection of dextrose-free bupivacaine 0.25% with fentanyl 0.005%
Number of subjects: 20
Study 2017469 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin injection
Number of subjects: 15
Study 2017469 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15
Study 7043116 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent feedback from utilization review coordinators
Number of subjects: 0
Study 7043116 — intervention group
Group type: COMPARATOR
Intervention: No feedback or physician advisor involvement
Number of subjects: 0
Study 31184207 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised medical scans
Number of subjects: 60
Study 31184207 — intervention group
Group type: COMPARATOR
Intervention: Generic scans
Number of subjects: 60
Study 31184207 — intervention group
Group type: COMPARATOR
Intervention: Medical illustrations
Number of subjects: 60
Study 30785851 — intervention group
Group type: EXPERIMENTAL
Intervention: DPT‐IPV vaccine co‐administered with HRV vaccine
Number of subjects: 292
Study 30785851 — intervention group
Group type: COMPARATOR
Intervention: DPT‐IPV vaccine staggered with HRV vaccine
Number of subjects: 292
Study 30227610 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine n-3 PUFA (2 g daily for three months)
Number of subjects: 112
Study 30227610 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 112
Study 26847975 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP) plus Treatment As Usual (TAU), n=8
Number of subjects: 25
Study 26847975 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based Cognitive Therapy (MBCT) plus Treatment As Usual (TAU), n=9
Number of subjects: 25
Study 26847975 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) only, n=8
Number of subjects: 25
Study 24989854 — intervention group
Group type: EXPERIMENTAL
Intervention: SST (Social Skills Training)
Number of subjects: 120
Study 24989854 — intervention group
Group type: EXPERIMENTAL
Intervention: SST-PTI (Social Skills Training with Parent & Teacher Involvement)
Number of subjects: 120
Study 24989854 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 120
Study 22285170 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sacral colpopexy (LSC)
Number of subjects: 0